8 results about "Tinnitus" patented technology

A system (300) and a method for improving hearing are described. In one embodiment of the system (300), a programming interface (16) is configured to communicate with a device. The system (300) analyzes, using a loudspeaker and a user interface (16) associated with the device, the left ear—and, separately, the right ear—of a patient at a frequency selected incrementally within a frequency range. The detected tinnitus frequencies are retested to further identify them. The system (300) then determines the range of hearing affected by tinnitus in the left and right ears.

Provided are an integrated tinnitus system for stimulating heterogeneous sensory organs through a user terminal, and an integrated tinnitus therapy method using same. The method may comprise the steps of: measuring a tinnitus frequency of a user; generating a vibration stimulation signal frequency having the same frequency as the tinnitus frequency, and an auditory stimulation signal frequency having the same frequency as the tinnitus frequency; transmitting the vibration stimulation signal and the auditory stimulation signal to the user; and storing tinnitus therapy information including durations of the vibration stimulation signal and the auditory stimulation signal received by the user.

An illustrative method includes: determining a preliminary estimate of the patient's tinnitus tone by allowing the patient to listen to and vary frequency and intensity of a first test tone within a predetermined first frequency range and a predetermined first intensity range to approximate the first test tone to the patient's tinnitus tone; defining a second frequency range and a second intensity range around the preliminary estimate of the patient's tinnitus tone; and determining a final estimate of the patient's tinnitus tone by allowing the patient to listen to and vary frequency and intensity of a second test tone within the second frequency range and the second intensity range to approximate the second test tone to the patient's tinnitus tone.

This invention belongs to the field of noise-induced tinnitus protection technology, specifically disclosing a noise-induced tinnitus protection device, including protective earmuffs, a headband, and an adaptive acoustic adjustment device. It achieves "precise targeting" of harmful noise through a Helmholtz resonant cavity array and innovatively introduces a volume adaptive adjustment mechanism, allowing the silencing frequency to dynamically match the individual and the environment. Furthermore, it combines a reed-non-Newtonian fluid coupling intelligent response unit to achieve real-time changes in acoustic impedance with noise intensity, realizing dynamic and adaptive secondary silencing. The entire device requires no electricity, ensuring wideband noise reduction while effectively attenuating key frequency bands that induce tinnitus, providing a comfortable, intelligent, and reliable active hearing protection solution from the root cause.

The invention relates to a device (1a, 1b, 1i.1iii) for tinnitus analysis, for automatically deriving a tinnitus therapy sound (Tt) from a tinnitus comparison sound (Tv) and for treating a tinnitus disease in a user, comprising means (6) for outputting an audio signal (AUD) and a controller (6a, 6b) for triggering output of the tinnitus therapy sound (Tt) as the audio signal (AUD). The tinnitus therapy sound (Tt) has a therapy base sound (T1), the frequency (f) of which is modulated around the tinnitus frequency (f1). The invention also relates to a method, a computer program product and a computer-readable medium for carrying out said steps.

Apparatuses and methods are described for improving blood flow and oxygen levels within an ear of a person for treatment of tinnitus, sudden sensorineural hearing loss, vertigo, temporomandibular joint disorder, or middle ear effusion using a head-worn appliance containing magnetic material that generates a magnetic field. The methods include placing the appliance on the person's head so that the magnetic material is in close proximity to a user's ear. The wearable appliance may be a configured as a headband, a headset, or in-ear inserts. If treating both of the person's ears, the wearable appliance should include two sets of magnets disposed on opposite sides of the person's head and in close proximity to the person's inner ears. The wearable appliance is oriented so that the north pole of the magnets faces the person's inner ear, and the south pole of the magnets faces away from the person's inner ear.

This invention belongs to the field of medical technology, specifically relating to the use of a Sigma 1 receptor agonist combined with a GABAAR receptor modulator in the preparation of a pharmaceutical composition for the prevention and / or treatment of tinnitus. This type of pharmaceutical composition exerts an anti-tinnitus effect by synergistically regulating the Sigma 1 and GABAAR receptor pathways, improving imbalances in auditory central nervous system excitability, abnormal neuroplasticity, and related neuroinflammatory responses. In particular, the combination therapy provided by this invention can be used to treat neurodegenerative tinnitus and drug-induced tinnitus.